Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
9 Meters Biopharma
9 Meters Biopharma
(NMTR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Larazotide
fabry disease
,
lysosomal storage diseases
,
chronic kidney failure
,
kidney diseases
,
renal insufficiency
Bevifimod
allergic rhinitis seasonal
,
nasal obstruction
,
sneezing
,
dental anxiety
,
restless legs syndrome
,
spinal cord injuries
,
type 1 diabetes mellitus
,
hiv infections
,
non-small-cell lung carcinoma
,
osteoarthritis
,
breast neoplasms
,
depression
,
neurologic manifestations
,
wounds and injuries
,
central nervous system diseases
,
spinal cord diseases
,
sleep wake disorders
,
inguinal hernia
,
peripheral nervous system diseases
,
radiculopathy
,
psoriasis
,
fibromyalgia
,
healthy volunteers/patients
,
neuralgia
,
partial epilepsies
,
diabetic neuropathies
,
epilepsy
,
pain
,
sleep initiation and maintenance disorders
,
seizures
,
postherpetic neuralgia
,
postoperative pain
,
anxiety disorders
,
low back pain
,
generalized anxiety disorder
,
complex partial epilepsy
,
back pain
,
breast feeding
,
bronchiolitis obliterans syndrome
,
neoplasms
,
bone neoplasms
,
intractable pain
,
phantom limb
,
burns
,
renal insufficiency
,
pharmacovigilance
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use